User preference for a portable syringe pump for iloprost infusion

PURPOSE: Administration of intravenous iloprost – a first-line European League Against Rheumatism (EULAR)-recommended choice for the treatment of scleroderma (SSc)-related digital vasculopathy – requires repeated treatment cycles of 6 hours per day in a hospital setting. During the infusion, patient...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Patient Relat Outcome Meas
Prif Awduron: Laria, Antonella, Lurati, Alfredo Maria, Re, Katia Angela, Marrazza, Maria Grazia, Mazzocchi, Daniela, Farina, Alberto, Scarpellini, Magda
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2015
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447001/
https://ncbi.nlm.nih.gov/pubmed/26056502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S81473
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg